Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression / Melissa P. DelBello en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2017 - Vol. 56 - No.12 ([02/02/2018])

Público ISBD [artículo]  inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.12 [02/02/2018] . - pp. 1015-1025 Título : Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression : A Double-Blind, Placebo-Controlled Study Tipo de documento: texto impreso Autores: Melissa P. DelBello, Autor ; Robert Goldman, Autor ; Debra Phillips, Autor Fecha de publicación: 2018 Artículo en la página: pp. 1015-1025 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión bipolar, Ensayo clínico, Lurasidona Resumen: To evaluate the efficacy and safety of lurasidone in children and adolescents with bipolar depression.Patients 10 to 17 years old with a DSM-5 diagnosis of bipolar I depression were randomized to 6 weeks of double-blind treatment with flexible doses of lurasidone 20 to 80 mg/day. Link: ./index.php?lvl=notice_display&id=9810 [artículo] Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression : A Double-Blind, Placebo-Controlled Study [texto impreso] / Melissa P. DelBello, Autor ; Robert Goldman, Autor ; Debra Phillips, Autor . - 2018 . - pp. 1015-1025. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.12 [02/02/2018] . - pp. 1015-1025 Palabras clave: Depresión bipolar, Ensayo clínico, Lurasidona Resumen: To evaluate the efficacy and safety of lurasidone in children and adolescents with bipolar depression.Patients 10 to 17 years old with a DSM-5 diagnosis of bipolar I depression were randomized to 6 weeks of double-blind treatment with flexible doses of lurasidone 20 to 80 mg/day. Link: ./index.php?lvl=notice_display&id=9810

---

1 (1 - 1 / 1)